JAMA February 2026 Treatment for Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
JAMA February 2026 Treatment for Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation
-
ナレーター：
-
著者：
概要
This clinical study investigated the most effective way to manage multiple brain metastases by comparing highly targeted stereotactic radiationagainst a broader approach that treats the entire brain while protecting the hippocampus. By measuring how cancer treatments affect a patient's symptom severity and daily functioning, researchers sought to identify which method preserves a higher quality of life for those with five to twenty tumors. The results demonstrated that the localized approach significantly outperformed the whole-brain method, leading to a meaningful reduction in patient-reported distress. Ultimately, the findings suggest that precision-focused radiation should be the preferred choice for maintaining the well-being of patients facing extensive brain involvement.